<departmental bulletin paper>
The QOL of the Hormone-Refractory Prostate Cancer Patients with Clinical Study CTL-precursor Oriented Vaccine

Creator
Language
Publisher
Date
Source Title
Vol
First Page
Last Page
Publication Type
Access Rights
JaLC DOI
Related DOI
Related URI
Relation
Abstract The purpose of this study was to clarify QOL of hormone-refractory prostate cancer patient undergoing clinical trial. Extracted contexts from record and information which CRN collected were 1671 items.... They were categorized into 3 aspects; physical, psychological and social. As a result, we considered it as follows. 1) The degradation of QOL was not significant in 3~12 months. 2) The most unbearable distress of the patient was a physical pain. Therefore, it is important to carry out the pain control. 3) The mental support is necessary so that the patient keep having hope. 4) The support from the family is important for the patient to have his good life.show more

Hide fulltext details.

pdf shsjournal2004-2_06 pdf 2.45 MB 1,204  

Details

Record ID
Peer-Reviewed
Subject Terms
ISSN
NCID
Type
Created Date 2009.04.22
Modified Date 2018.08.31

People who viewed this item also viewed